Best Online Share/Stock Trading & Investment Broker in India - Mastertrust

Sun Pharmaceutical Industries Ltd.

BSE : 124715 NSE : SUNPHARMA ISIN : INE044A01036 Industry : Pharmaceuticals & Drugs
813.50
Change: 0.30 (0.04 %)
As on 26-Oct-2021 12:00 AM
Prev.Close 813.20
Open 817.00
Day's High 823.90
Day's Low 806.30
Mkt.Cap ( Cr.) 195,185.90
Face Value 1.00
PE Ratio 32.49
PB Ratio 5.73

52 Week High Low

Low: 452.25
High: 851.00
LTP:813.50

Lifetime High Low

Low: 312.00
High: 1,200.80
LTP:813.50

Sun Pharmaceutical Industries Ltd.

BSE : 124715 NSE : SUNPHARMA ISIN : INE044A01036 Industry : Pharmaceuticals & Drugs
813.55
B S Sip
Change: 0.55 (0.07 %)
As on 26-Oct-2021 12:00 AM
Prev.Close 813.00
Open 819.50
Day High 823.90
Day Low 807.00
Mkt.Cap ( Cr. ) 195,197.90
Face Value 1.00
P/E Ratio 32.49
PB Ratio 5.73

52 Week High Low

Low:452.60
High:850.00
LTP:813.55

Lifetime High Low

Low:315.20
High:1,200.70
LTP:813.55

P/E Ratio

52 W L(14.96)
52 W H(40.26)

P/E Ratio

52 W L(14.96)
52 W H(40.26)
Had I Invested a sum of 1,00,000 on the same day 5 years ago,the money would have become 108843.99 ( a of 1.71 p.a.)

Key Levels

Support Level 1 798.75
Support Level 2 784.30
Resistance Level 1 824.45
Resistance Level 2 835.70

Moving Average

20 Days 818.02
50 Days 792.80
100 Days 745.09
200 Days 686.09
Jagsonpal Pharmaceuticals Ltd. 176.40 Change: 17.20 (10.80%)
PE : 16.92
1Y Return: 354.05%

B S
AMI Organics Ltd. 1,105.95 Change: 93.95 (9.28%)
PE : 68.34
1Y Return: 0.00%

B S
Beta Drugs Ltd. 566.45 Change: 44.20 (8.46%)
PE : 42.83
1Y Return: 339.11%

B S
Hikal Ltd. 501.45 Change: 35.95 (7.72%)
PE : 34.35
1Y Return: 192.56%

B S
FY 2021FY 2020FY 2019FY 2018FY 2017
EBDITA Margin (%)21.3330.5224.4117.768.07
PBT Margin (%)14.8823.515.802.36-0.22
PAT Margin (%)14.7923.216.582.58-0.29
ROCE (%)7.7112.194.312.380.75
ROE (%)8.6613.603.621.41-0.11
FY 2021FY 2020FY 2019FY 2018FY 2017
Total Income ( Cr.)12,964.7614,042.8511,589.3610,234.108,373.66
Gross Profit ( Cr.)2,829.243,814.562,486.781,717.99405.48
Profit Before Tax ( Cr.)2,152.873,253.00719.45280.25-16.80
Tax ( Cr.)13.1741.86-97.15-25.396.04
Profit After Tax ( Cr.)2,139.703,211.14816.60305.64-22.84
NAME DESIGNATION
Israel Makov Chairman
Dilip S Shanghvi Managing Director
Sailesh T Desai Whole Time Director
Kalyanasundaram Subramanian Whole Time Director
Sudhir V Valia Non Independent & Non Executive Director
Rekha Sethi Non Executive Independent Director
Vivek Chaand Sehgal Non Executive Independent Director
Gautam Doshi Non Executive Independent Director
Pawan Goenka Non Executive Independent Director
Rama Bijapurkar Non Executive Independent Director
Sunil R Ajmera Company Secretary
Scheme Name AUM% Value(Rs. Cr.) Holding Date
ICICI Prudential Value Discovery Fund - Growth Know More 7.79 1,772.22 30-Sep-2021
SBI - ETF Nifty 50 Know More 1.16 1,385.77 30-Sep-2021
SBI Equity Hybrid Fund - Regular Plan - IDCW Know More 1.72 818.25 30-Sep-2021
SBI - ETF Sensex Know More 1.35 806.34 30-Sep-2021
ICICI Prudential Equity & Debt Fund - Growth Know More 4.11 766.23 30-Sep-2021
Sun Pharmaceutical Industries launches novel formulation in cough management ‘Chericof 12’
Type: NEWS
Date: 28-Sep-2021 11:16 AM
Chericof 12 is approved for patients of age group six years and above
Sun Pharma surges on foraying into nutrition bar segment
Type: MOVERS TODAY
Date: 08-Sep-2021 01:48 PM
The product has been launched in two different variants, Revital Energy NXT and Revital Protein NXT
Sun Pharma forays into nutrition bar segment
Type: NEWS
Date: 08-Sep-2021 01:31 PM
The product has been launched in two different variants, Revital Energy NXT and Revital Protein NXT
Sun Pharmaceutical rises on selling step-down subsidiary
Type: MOVERS TODAY
Date: 02-Sep-2021 12:03 PM
Kayaku Co. has ceased to be the subsidiary of the company with effect from September 1, 2021
Sun Pharmaceutical sells step-down subsidiary
Type: NEWS
Date: 02-Sep-2021 11:19 AM
Thus Kayaku Co. has ceased to be the subsidiary of the company with effect from September 1, 2021
Sun Pharma gets exclusive right to commercialize Winlevi in US, Canada
Type: NEWS
Date: 01-Sep-2021 10:15 AM
Cassiopea will be the exclusive supplier of the product, which is expected to be available in the US in the fourth quarter of 2021